| | Description | value | Enriched genes |
| | G protein-coupled amine receptor activity | 3.9410–15 | ADRB2, CHRM3, ADRA1A, CHRM2, ADRA2A, ADRB1, ADRA2C, ADRA1D | | Neurotransmitter receptor activity | 3.5810–09 | CHRM3, CHRM1, CHRM2, CHRNA2, OPRM1, GABRA1, ADRB1 | | Steroid hormone receptor activity | 7.5810–09 | PGR, NR3C2, RXRA, NR3C1, AR, PPARG | | Nuclear receptor activity | 1.6510–07 | PGR, RXRA, NR3C1, AR, PPARG | | Transcription factor activity, direct ligand regulated sequence-specific DNA binding | 1.6510–07 | PGR, RXRA, NR3C1, AR, PPARG | | G protein-coupled neurotransmitter receptor activity | 3.6410–07 | CHRM3, CHRM2, OPRM1, ADRB1 | | Protein heterodimerization activity | 8.3010–07 | ADRA1A, ADRA1B, BCL2, BAX, JUN, RXRA, ADRA2A, ADRB1, PPARG, ADRA2C | | Hormone binding | 2.8710–06 | CHRM3, CHRNA2, NR3C1, AR, ACHE | | Anion: cation symporter activity | 4.3110–06 | SLC6A4, SLC6A2, SLC6A3 | | Acetylcholine receptor activity | 4.3110–06 | CHRM3, CHRM2, CHRNA2 | | Catecholamine binding | 4.3110–06 | ADRB2, ADRA2A, ADRA2C | | Ammonium ion binding | 9.1910–06 | CHRM3, CHRNA2, SLC6A4, ACHE | | Adrenergic receptor binding | 1.3210–05 | ADRA2A, ADRB1, ADRA2C | | Nuclear receptor binding | 1.5810–05 | NCOA2, RXRA, NCOA1 | | Phosphatidylinositol phospholipase C activity | 1.8710–05 | CHRM3, CHRM1, CHRM5 | | Neurotransmitter: sodium symporter activity | 2.2010–05 | SLC6A4, SLC6A2, SLC6A3 | | Phospholipase C activity | 3.8710–05 | CHRM3, CHRM1, CHRM5 | | Chloride transmembrane transporter activity | 5.4410–05 | SLC6A4, GABRA1, SLC6A2, SLC6A3 | | Channel activity | 6.5710–05 | SCN5A, KCNH2, CHRNA2, OPRM1, GABRA1, BCL2, BAX | | Passive transmembrane transporter activity | 6.6810–05 | SCN5A, KCNH2, CHRNA2, OPRM1, GABRA1, BCL2, BAX |
|
|
